Continuous infusion 5-fluorouracil (5FU) as a novel treatment for heavily pretreated prostate cancer patients: An update.

被引：4
|
作者：
Manogue, Charlotte
Cotogno, Patrick
Moses, Marcus Marie
Barata, Pedro C.
Layton, Jodi Lyn
Sartor, A. Oliver
Lewis, Brian E.
机构：
[1] Tulane Univ, Ctr Canc, New Orleans, LA 70118 USA
[2] Tulane Canc Ctr, Off Clin Res, New Orleans, LA USA
[3] Tulane Univ, New Orleans, LA 70118 USA
[4] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA
[5] Tulane Med Sch, New Orleans, LA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.319
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
319
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Evaluating 5FU plasma level in colorectal cancer chemotherapy patients through continuous 5FU infusion
    Sakuyama, Naoki
    Sato, Tsuyoshi
    Kishine, Kenji
    Nagayasu, Kiichi
    Nakatani, Akinori
    Kitajima, Masayuki
    ANNALS OF ONCOLOGY, 2022, 33 : S542 - S542
  • [12] Radiotherapy (RT) with intravenous and endolymphatic infusion 5-fluorouracil (5FU) in advanced inoperable rectal cancer
    Bondar, G. V.
    Psaras, G. G.
    Basheev, V. H.
    Zolotukhin, S. E.
    Bulatova, M. A.
    Dolgova, M. V.
    ANNALS OF ONCOLOGY, 2004, 15 : 80 - 80
  • [13] VNB and 5FU prolonged infusion in pretreated advanced breast cancer patients
    Tralongo, P
    Aiello, R
    Lavenia, G
    Paolello, C
    Salice, P
    Failla, G
    BREAST, 1997, 6 (05): : P909 - P909
  • [14] INTERACTION OF 5-FLUOROURACIL (5FU) WITH TUMOR ISCHEMIA
    EIBLEIBESFELDT, B
    STORZ, V
    KUMMERMEHR, J
    SCHALHORN, A
    BLUT, 1986, 53 (03): : 253 - 253
  • [15] INFLUENCE OF AGE ON PHARMACOKINETICS OF 5-FLUOROURACIL (5FU)
    SCHILCHER, RB
    DECKER, DA
    EVANS, LJ
    MARTINO, S
    KRESGE, C
    YOUNG, JD
    SAMAL, BA
    SINGHAKOWINTA, A
    BREAST CANCER RESEARCH AND TREATMENT, 1984, 4 (04) : 347 - 347
  • [16] INTERACTION OF MEROMELIA GENE AND 5-FLUOROURACIL (5FU)
    IGARASHI, E
    YASUDA, M
    TERATOLOGY, 1988, 38 (05) : 533 - 534
  • [17] THE INFLUENCE OF CIMETIDINE ON THE PHARMACOKINETICS OF 5-FLUOROURACIL (5FU)
    HARVEY, VJ
    SLEVIN, ML
    DILLOWAY, M
    CLARK, PI
    JOHNSTON, A
    LANT, AF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 362 - 362
  • [18] CONTINUOUS INFUSION (CI) OF 5-FLUOROURACIL (5FU) AND CISPLATIN (DDP) FOR METASTATIC COLORECTAL-CANCER (MCRC) AND OTHER GASTROINTESTINAL MALIGNANCIES
    MADAJEWICZ, S
    BURK, M
    DAINER, P
    FIORE, J
    JOHNSON, H
    OSTROW, S
    SCHUBACH, W
    VIOLA, M
    KENNEDY, D
    VITKUN, C
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 201 - 201
  • [19] Influence of 5-fluorouracil (5FU) on cancer survival in patients with microsatellite unstable (MSI) colorectal cancer
    Carethers, JM
    Smith, EJ
    Nguyen, L
    Tajima, A
    Doctolero, RT
    Cabrera, BL
    Goel, A
    Arnold, CN
    Boland, CR
    Miyai, K
    Behling, CA
    GASTROENTEROLOGY, 2002, 122 (04) : A600 - A600
  • [20] Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer
    I Chau
    A Webb
    D Cunningham
    M Hill
    J S Waters
    A Norman
    A Massey
    British Journal of Cancer, 2001, 85 : 1258 - 1264
12345